{"name":"Altair Therapeutics, Inc.","slug":"altair-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AIR645","genericName":"AIR645","slug":"air645","indication":"Inflammatory airway disease (specific indication under investigation in Phase 2)","status":"phase_2"}]}],"pipeline":[{"name":"AIR645","genericName":"AIR645","slug":"air645","phase":"phase_2","mechanism":"AIR645 is an inhaled biologic that targets airway inflammation through a mechanism involving immune modulation in the respiratory tract.","indications":["Inflammatory airway disease (specific indication under investigation in Phase 2)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE91SjhUaHU5VWJPZlJCQUZIYWwtb1Fnb2ZpcVZXeW5fQkhnckR2UDBDdFFuS0lZZkdiTFlNaWlzM2xGMU90c2FRWHdSdEF2bHB0NlpjMFlXbmRMWGtZbVhpQ1VSYmJBeGM3bmc?oc=5","date":"2024-09-06","type":"pipeline","source":"Market.us","summary":"Nanotechnology in Biotech Market Size | CAGR Of 9.5% - Market.us","headline":"Nanotechnology in Biotech Market Size | CAGR Of 9.5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9nYnh5VnFkZ0hubm9TeUw0ck5JRGZBZm1WcnF1Y3VBUTlGc3NJek9NTmNrYVNsN2MxenBKZlptYVFiNmRRaFFZVGFGMWZUNUY4LTViQm5aaURMR0xfU0lF?oc=5","date":"2024-05-22","type":"pipeline","source":"nature.com","summary":"One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan - nature.com","headline":"One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular de","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-07-05","type":"regulatory","source":"NBC New York","summary":"FDA: Altaire Recalls Eye Drops, Eye Ointments Sold at Walgreens Due to Non-Sterility Concerns - NBC New York","headline":"FDA: Altaire Recalls Eye Drops, Eye Ointments Sold at Walgreens Due to Non-Sterility Concerns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUFF0NFhFWGxzXzNlWXRuWS11Z2piV2tNbTVweEhTd01uNUZxaFh3cGFoZ1JCbUNUcFE3R2xDR2pYZmpHWG1SNDdYa3RCWGgwUWlielhrcFpTbUpoV1JXZm56TVpNTGVMU1R1dTFWbU5LVmdBbU1DUGs4VXJXX3hEaEptT3lyZHpTUEdXT3pnOVRTN1l4cGpyY3hoRE1JODdFZWcyTEdDdjVSOTRO?oc=5","date":"2015-07-24","type":"pipeline","source":"Technology Networks","summary":"Dauntless Pharmaceuticals Launches New Company - Technology Networks","headline":"Dauntless Pharmaceuticals Launches New Company","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}